Clinical Trial

A Study of Herbal Supplements in Cancer Survivors With Constipation

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to find out whether MZRW is an effective treatment for constipation in cancer survivors. The researchers will compare MZRW with placebo, a pill that looks like MZRW and is given in the same way, but contains no medication. The researchers will also study the effect MZRW has on the gut microbiome. The gut microbiome is a diverse community of microorganisms living in the digestive system, essential for digestion and immune function.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-21; most recent amendment 2026-05-20.
Trial Details
NCT Number NCT07091084
Lead Sponsor Memorial Sloan Kettering Cancer Center
Conditions Constipation, Cancer, Functional Constipation
Enrollment 70 participants
Start Date 2025-07-15
Primary Completion 2028-07-15 (estimated)
Study Completion 2028-07-15 (estimated)
Updated on ClinicalTrials.gov 2026-05-22